Cargando…

Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography

BACKGROUND: Diagnosis and evaluation of cardiac sarcoidosis (CS) are mainly based on the combined use of cardiac magnetic resonance imaging (CMR) and (18)F fludeoxyglucose positron emission tomography (FDG). Though these modalities can detect the pathological feature of the disease, combined assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Kenji, Nagao, Michinobu, Yamamoto, Atsushi, Serizawa, Naoki, Ishizaki, Umiko, Suzuki, Atsushi, Sakai, Akiko, Watanabe, Eri, Momose, Mitsuru, Kuji, Ichiei, Abe, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218105/
https://www.ncbi.nlm.nih.gov/pubmed/34191189
http://dx.doi.org/10.1186/s41824-019-0056-4
_version_ 1783710719218286592
author Fukushima, Kenji
Nagao, Michinobu
Yamamoto, Atsushi
Serizawa, Naoki
Ishizaki, Umiko
Suzuki, Atsushi
Sakai, Akiko
Watanabe, Eri
Momose, Mitsuru
Kuji, Ichiei
Abe, Koichiro
author_facet Fukushima, Kenji
Nagao, Michinobu
Yamamoto, Atsushi
Serizawa, Naoki
Ishizaki, Umiko
Suzuki, Atsushi
Sakai, Akiko
Watanabe, Eri
Momose, Mitsuru
Kuji, Ichiei
Abe, Koichiro
author_sort Fukushima, Kenji
collection PubMed
description BACKGROUND: Diagnosis and evaluation of cardiac sarcoidosis (CS) are mainly based on the combined use of cardiac magnetic resonance imaging (CMR) and (18)F fludeoxyglucose positron emission tomography (FDG). Though these modalities can detect the pathological feature of the disease, combined assessment has not been fully examined. Multimodality image fusion is known to be useful for further comprehension, while most image interpretation is performed with a side by side comparison in clinical routine. We investigated the similarity and discrepancy of active inflammation, regional fibrosis, and wall function by image fusion of CMR and FDG. METHODS: Patients with CS who underwent both CMR and FDG were retrospectively enrolled. The extent of myocardial late gadolinium enhancement (LGE) in left ventricle (LGE volume), cardiac function, and volume (left ventricular ejection fraction, LVEF; end-diastolic volume, EDV) was measured from CMR. The FDG uptake in whole myocardium (whole SUVmax), cardiac metabolic volume (CMV), and cardiac metabolic activity (CMA) was calculated from FDG. CMR and FDG were fused and divided into AHA 17 model for segmental analysis. Wall motion, the magnitude of LGE in myocardial wall (LGE%wall), and corresponding FDG uptake (segmental SUVmax) were analyzed. RESULTS: Forty-one patients were retrospectively enrolled. In patients with FDG uptake, LVEF inversely correlated to LGE volume and positively correlated to SUVmax (r = − 0.56, p < 0.0001, and r = 0.08, p = 0.048, respectively). Discrepancy between LGE volume and CMV showed a significant positive correlation to whole SUVmax and CMA (r = 0.49, p < 0.0001, and r = 0.96, p < 0.0001, respectively). In image fusion analysis, segmental SUVmax showed a significant inverse correlation to LGE%wall (Spearman’s rank correlation coefficient; r = − 0.15, p = 0.008). LGE%wall also showed significant inverse correlation to wall motion (r = − 0.13, p = 0.0011). CONCLUSION: Combined and fusion analysis with CMR and FDG demonstrated the discrepancy of myocardial inflammation and extensive fibrosis. Active inflammation was present in the earlier stage of myocardial fibrosis and was found to be less in the wall with advanced fibrosis and remodeling. Combined analysis of CMR and FDG can incrementally reclassify the pathological stage of CS.
format Online
Article
Text
id pubmed-8218105
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82181052021-06-24 Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography Fukushima, Kenji Nagao, Michinobu Yamamoto, Atsushi Serizawa, Naoki Ishizaki, Umiko Suzuki, Atsushi Sakai, Akiko Watanabe, Eri Momose, Mitsuru Kuji, Ichiei Abe, Koichiro Eur J Hybrid Imaging Original Article BACKGROUND: Diagnosis and evaluation of cardiac sarcoidosis (CS) are mainly based on the combined use of cardiac magnetic resonance imaging (CMR) and (18)F fludeoxyglucose positron emission tomography (FDG). Though these modalities can detect the pathological feature of the disease, combined assessment has not been fully examined. Multimodality image fusion is known to be useful for further comprehension, while most image interpretation is performed with a side by side comparison in clinical routine. We investigated the similarity and discrepancy of active inflammation, regional fibrosis, and wall function by image fusion of CMR and FDG. METHODS: Patients with CS who underwent both CMR and FDG were retrospectively enrolled. The extent of myocardial late gadolinium enhancement (LGE) in left ventricle (LGE volume), cardiac function, and volume (left ventricular ejection fraction, LVEF; end-diastolic volume, EDV) was measured from CMR. The FDG uptake in whole myocardium (whole SUVmax), cardiac metabolic volume (CMV), and cardiac metabolic activity (CMA) was calculated from FDG. CMR and FDG were fused and divided into AHA 17 model for segmental analysis. Wall motion, the magnitude of LGE in myocardial wall (LGE%wall), and corresponding FDG uptake (segmental SUVmax) were analyzed. RESULTS: Forty-one patients were retrospectively enrolled. In patients with FDG uptake, LVEF inversely correlated to LGE volume and positively correlated to SUVmax (r = − 0.56, p < 0.0001, and r = 0.08, p = 0.048, respectively). Discrepancy between LGE volume and CMV showed a significant positive correlation to whole SUVmax and CMA (r = 0.49, p < 0.0001, and r = 0.96, p < 0.0001, respectively). In image fusion analysis, segmental SUVmax showed a significant inverse correlation to LGE%wall (Spearman’s rank correlation coefficient; r = − 0.15, p = 0.008). LGE%wall also showed significant inverse correlation to wall motion (r = − 0.13, p = 0.0011). CONCLUSION: Combined and fusion analysis with CMR and FDG demonstrated the discrepancy of myocardial inflammation and extensive fibrosis. Active inflammation was present in the earlier stage of myocardial fibrosis and was found to be less in the wall with advanced fibrosis and remodeling. Combined analysis of CMR and FDG can incrementally reclassify the pathological stage of CS. Springer International Publishing 2019-06-14 /pmc/articles/PMC8218105/ /pubmed/34191189 http://dx.doi.org/10.1186/s41824-019-0056-4 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Fukushima, Kenji
Nagao, Michinobu
Yamamoto, Atsushi
Serizawa, Naoki
Ishizaki, Umiko
Suzuki, Atsushi
Sakai, Akiko
Watanabe, Eri
Momose, Mitsuru
Kuji, Ichiei
Abe, Koichiro
Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title_full Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title_fullStr Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title_full_unstemmed Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title_short Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
title_sort discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)f fluorodeoxyglucose positron emission tomography
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218105/
https://www.ncbi.nlm.nih.gov/pubmed/34191189
http://dx.doi.org/10.1186/s41824-019-0056-4
work_keys_str_mv AT fukushimakenji discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT nagaomichinobu discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT yamamotoatsushi discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT serizawanaoki discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT ishizakiumiko discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT suzukiatsushi discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT sakaiakiko discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT watanabeeri discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT momosemitsuru discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT kujiichiei discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography
AT abekoichiro discrepancybetweensignificantfibrosisandactiveinflammationinpatientswithcardiacsarcoidosiscombinedandimagefusionanalysisofcardiacmagneticresonanceand18ffluorodeoxyglucosepositronemissiontomography